Jul 11, 2022 |
Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025Jun 01, 2022 |
Annexon Biosciences to Present Data Highlighting Novel Approach to Treating Complement-Driven Diseases at Upcoming Medical MeetingsMay 09, 2022 |
Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial ResultsApr 07, 2022 |
Annexon Biosciences Completes Enrollment in ARCHER Phase 2 Trial of Novel C1q Inhibitor, ANX007, in Patients with Geographic AtrophyApr 04, 2022 |
Annexon Biosciences to Participate in the 21st Annual Needham Virtual Healthcare Conference
Displaying 1 - 10 of 15